Jacobs, L.;                     Wauters, N.;                     Lablad, Y.;                     Morelle, J.;                     Taghavi, M.    
        Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. Antibodies 2024, 13, 21.
    https://doi.org/10.3390/antib13010021
    AMA Style
    
                                Jacobs L,                                 Wauters N,                                 Lablad Y,                                 Morelle J,                                 Taghavi M.        
                Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. Antibodies. 2024; 13(1):21.
        https://doi.org/10.3390/antib13010021
    
    Chicago/Turabian Style
    
                                Jacobs, Lucas,                                 Nader Wauters,                                 Yahya Lablad,                                 Johann Morelle,                                 and Maxime Taghavi.        
                2024. "Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria" Antibodies 13, no. 1: 21.
        https://doi.org/10.3390/antib13010021
    
    APA Style
    
                                Jacobs, L.,                                 Wauters, N.,                                 Lablad, Y.,                                 Morelle, J.,                                 & Taghavi, M.        
        
        (2024). Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. Antibodies, 13(1), 21.
        https://doi.org/10.3390/antib13010021